Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drugs

Showing results (901-910 of 7,076) with videos related to

Pageof 708
Sort By:
Drugs|January 1, 1994
Treatment recommendations for osteosarcoma and adult soft tissue sarcomasP Picci, S Ferrari, G Bacci, et al.
Drugs|January 1, 1994
Gallopamil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in ischaemic heart diseaseR N Brogden, P Benfield
Drugs|January 1, 1993
Long term effects of sustained release verapamil on the renal and systemic haemodynamic parameters in hypertensive patients with mild to severe chronic renal failureD C Schohn, H A Jahn, M Maareck
Drugs|January 1, 1993
Calcium antagonists and ACE inhibitors. Effect on endothelium and vascular smooth muscleT F Lüscher, Z Yang
Drugs|January 1, 1993
Individualised selection of antihypertensive therapyL H Opie
Drugs|January 1, 1993
Epidemiology of high blood pressure and obesityF J Martínez, J M Sancho-Rof
Drugs|January 1, 1993
Diagnosis of insulin resistanceF J Martínez, E Villa, J Serrano, et al.
Drugs|January 1, 1993
Hypertension and insulin resistance. Glycaemia and insulinaemia in overweight hypertensive patientsB Weichenhain, H J van Kooten, E Standl
Drugs|January 1, 1993
Influence of antihypertensive drugs on exercise capacityR Fagard, J Staessen, L Thijs, et al.
Drugs|January 1, 1993
Pharmacological aspects of calcium antagonism. Short term and long term benefitsW G Nayler
Pageof 708

Showing results (901-910 of 7,076) with videos related to

Sort By:
Pageof 708
Drugs|January 1, 1994
Treatment recommendations for osteosarcoma and adult soft tissue sarcomasP Picci, S Ferrari, G Bacci, et al.
Drugs|January 1, 1994
Gallopamil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in ischaemic heart diseaseR N Brogden, P Benfield
Drugs|January 1, 1993
Long term effects of sustained release verapamil on the renal and systemic haemodynamic parameters in hypertensive patients with mild to severe chronic renal failureD C Schohn, H A Jahn, M Maareck
Drugs|January 1, 1993
Calcium antagonists and ACE inhibitors. Effect on endothelium and vascular smooth muscleT F Lüscher, Z Yang
Drugs|January 1, 1993
Individualised selection of antihypertensive therapyL H Opie
Drugs|January 1, 1993
Epidemiology of high blood pressure and obesityF J Martínez, J M Sancho-Rof
Drugs|January 1, 1993
Diagnosis of insulin resistanceF J Martínez, E Villa, J Serrano, et al.
Drugs|January 1, 1993
Hypertension and insulin resistance. Glycaemia and insulinaemia in overweight hypertensive patientsB Weichenhain, H J van Kooten, E Standl
Drugs|January 1, 1993
Influence of antihypertensive drugs on exercise capacityR Fagard, J Staessen, L Thijs, et al.
Drugs|January 1, 1993
Pharmacological aspects of calcium antagonism. Short term and long term benefitsW G Nayler
Pageof 708